Alpha Teknova (TKNO) Scheduled to Post Earnings on Thursday

Alpha Teknova (NASDAQ:TKNO) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, November 7th. Parties interested in listening to the company’s conference call can do so using this link.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.03. The business had revenue of $9.61 million during the quarter, compared to analysts’ expectations of $9.50 million. Alpha Teknova had a negative net margin of 98.08% and a negative return on equity of 37.00%. During the same period last year, the company posted ($0.25) EPS. On average, analysts expect Alpha Teknova to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Alpha Teknova Stock Up 0.7 %

Shares of NASDAQ TKNO opened at $7.11 on Thursday. The stock has a market capitalization of $378.98 million, a price-to-earnings ratio of -7.65 and a beta of 0.43. Alpha Teknova has a 12-month low of $1.15 and a 12-month high of $7.49. The company has a current ratio of 4.76, a quick ratio of 3.28 and a debt-to-equity ratio of 0.16. The firm’s 50-day moving average price is $5.24 and its 200-day moving average price is $3.29.

Analysts Set New Price Targets

Separately, Stephens reaffirmed an “overweight” rating and issued a $5.00 price objective on shares of Alpha Teknova in a research note on Wednesday, July 10th.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.